03:00 Mon 14 Mar 2016
Tekcapital plc - New Technology License
("
New Technology License
Acquisition of exclusive license to a patent-pending improvement for non-invasive glucose testing technology
New technology may replace the need for invasive blood testing for diabetics
The exclusively licensed US patent application 62/288,747 entitled "Saliva glucose measurement devices and methods" describes a safe, fast and non-invasive method and device to collect and sample glucose in saliva for both human and companion animals. The biosensor device allows trace saliva fluid samples from a biological surface to be obtained for electrochemical analysis and the subsequent detection of analytes using disposable biosensor strips. The Directors of
Market potential
According to the
Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin, a hormone that regulates blood sugar, or when the body cannot effectively use the insulin it produces. Hyperglycaemia, or raised blood sugar, is a common effect of uncontrolled diabetes and over time may lead to serious damage to many of the body's systems, especially the nerves and blood vessels. Companion animals, particularly dogs and cats, also have presented an increasing growth of diabetes cases.
The current standard for self-glucose monitoring technologies, used throughout the world to measure blood glucose in diabetics, is to draw a blood sample and place the blood on a strip for insertion into a glucometer. There is a general dislike of the pain and inconvenience caused by this method, leading to fewer tests being performed, which may result in inadequate blood glucose control and complications from the disease. Furthermore, the testing itself can also cause blood-borne infection. Dog and cat owners routinely face challenges in gathering blood samples from their dogs and cats, running the risk of infection around paws, ears, legs, together with other areas, often deciding to pay for regular and expensive visits to veterinary clinics.
Dr.
1 Mordor Intelligence,
For further information please contact:
|
+1 305 200 3450 Ext 305 |
|
|
|
|
|
|
|
|
+44 (0)20 3328 5656 |
|
|
|
|
|
|
|
|
+44 (0) 20 3137 1904 |
|
|
||
|
|
|
|
+44 (0) 20 7933 8780 |
|
|
||
This information is provided by RNS
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE